Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1610

1.

A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.

Guest JF, Ruiz FJ, Russ J, Gupta RD, Mihai A, Greener M.

Curr Med Res Opin. 2005 Feb;21(2):271-80.

PMID:
15801998
[PubMed - indexed for MEDLINE]
2.

Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK.

Guest JF, Ruiz FJ, Greener MJ, Trotman IF.

Eur J Cancer Care (Engl). 2006 Mar;15(1):65-73.

PMID:
16441679
[PubMed - indexed for MEDLINE]
3.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
[PubMed - indexed for MEDLINE]
4.

Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.

Ripamonti C, Fagnoni E, Campa T, Brunelli C, De Conno F.

Support Care Cancer. 2006 May;14(5):400-7. Epub 2006 Feb 17.

PMID:
16485087
[PubMed - indexed for MEDLINE]
5.

Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.

Guest JF, Hart WM, Cookson RF.

Pharmacoeconomics. 1998 Sep;14(3):285-97.

PMID:
10186467
[PubMed - indexed for MEDLINE]
6.

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.

Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.

Eur J Pain. 2008 Nov;12(8):1040-6. doi: 10.1016/j.ejpain.2008.01.013. Epub 2008 Mar 18.

PMID:
18353696
[PubMed - indexed for MEDLINE]
7.

Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy.

Roggeri D, Saramin C, Terrazzani G, Zusso M, Giusti P, Chinellato A.

Pharmacol Res. 2007 Oct;56(4):329-34. Epub 2007 Aug 6.

PMID:
17851088
[PubMed - indexed for MEDLINE]
8.

Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.

van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WW.

Curr Med Res Opin. 2003;19(6):457-69.

PMID:
14594516
[PubMed - indexed for MEDLINE]
9.
10.

[Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].

Binhas M, Krakowski I, Marty J.

Ann Fr Anesth Reanim. 2007 Jun;26(6):502-15. Epub 2007 Jun 8. Review. French.

PMID:
17560755
[PubMed - indexed for MEDLINE]
11.

Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.

Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R, Mahmoud R.

J Clin Oncol. 1998 Apr;16(4):1588-93.

PMID:
9552070
[PubMed - indexed for MEDLINE]
12.
14.

Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.

Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R.

Eur J Health Econ. 2006 Dec;7(4):290-6.

PMID:
16983521
[PubMed - indexed for MEDLINE]
15.

Opioid use in palliative care of children and young people with cancer.

Hewitt M, Goldman A, Collins GS, Childs M, Hain R.

J Pediatr. 2008 Jan;152(1):39-44. Epub 2007 Nov 5.

PMID:
18154896
[PubMed - indexed for MEDLINE]
16.

Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain.

Allan L, Richarz U, Simpson K, Slappendel R.

Spine (Phila Pa 1976). 2005 Nov 15;30(22):2484-90.

PMID:
16284584
[PubMed - indexed for MEDLINE]
17.
18.

Therapy switching in patients receiving long-acting opioids.

Berger A, Hoffman DL, Goodman S, Delea TE, Seifeldin R, Oster G.

Ann Pharmacother. 2004 Mar;38(3):389-95. Epub 2004 Jan 12.

PMID:
14742831
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.

Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GL, Richarz U, Simpson K.

Curr Med Res Opin. 2004 Sep;20(9):1419-28.

PMID:
15383190
[PubMed - indexed for MEDLINE]
20.

Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.

Tawfik MO, Bryuzgin V, Kourteva G; FEN-INT-20 Study Group.

Curr Med Res Opin. 2004 Mar;20(3):259-67.

PMID:
15025835
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk